Trial Details
COMPLETEDBasic Information
| Clinical ID | c885 |
|---|---|
| Identifier | NCT00744016 |
| Trial Title | Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Granulated mesalamine|DRUG: Placebo |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Bristol |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-12-04 |
|---|---|
| Primary Completion Date | 2025-05-07 |
| Completion Date | 2025-10-07 |